Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-05-25FDA Approved: LIALDA — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for LIALDA (mesalamine) from Takeda Pharmaceuticals America, Inc. LIALDA is indicated for ulcera…
-
CLINICAL_TRIALS trial_result · 2021-05-18Clinical Trial Update: 5-HTP in Patients With IBD in Clinical and Biologic Remission:Effect on Fatigue Scores [Phase 2]
Phase 2 trial evaluating 5-HTP in patients with inflammatory bowel disease in clinical and biologic remission to assess effects on fatigue s…
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Anthocyanin Rich Extract (ACRE) in Patients With Ulcerative Colitis [Phase 2]
Phase 2 clinical trial investigating Anthocyanin Rich Extract (ACRE) in patients with Ulcerative Colitis has been completed.
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis [Phase 3]
Phase 3 trial of SHP647 as induction therapy in moderate to severe ulcerative colitis was terminated with results posted.
-
CLINICAL_TRIALS withdrawal · 2021-05-06Clinical Trial Update: A Study of Mirikizumab (LY3074828) in Participants With Ulcerative Colitis [Phase 3]
Phase 3 study of mirikizumab in ulcerative colitis has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: A Dose-finding Study of OPC-6535 in Patients With Active Ulcerative Colitis [Phase 2]
Phase 2 dose-finding study of OPC-6535 in active ulcerative colitis has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Fecal Microbiota Transplantation (FMT) in the Treatment of Pouchitis [Phase 2]
Phase 2 clinical trial update on fecal microbiota transplantation for pouchitis and ulcerative colitis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-26Clinical Trial Update: Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Ulcerative Colitis [Phase 3]
Phase 3 trial of SHP647 in moderate-to-severe ulcerative colitis was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-21Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis [Phase 3]
Phase 3 trial evaluating filgotinib for induction and maintenance of remission in adults with moderately to severely active ulcerative colit…
-
CLINICAL_TRIALS trial_result · 2021-04-15Clinical Trial Update: A Study of Tofacitinib in Patients With Ulcerative Colitis in Stable Remission [Phase 4]
Phase 4 clinical trial evaluating tofacitinib in ulcerative colitis patients in stable remission; study terminated with results posted in 20…
-
CLINICAL_TRIALS trial_result · 2021-04-05Clinical Trial Update: A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors [Phase 3]
Phase 3 trial comparing etrolizumab to adalimumab and placebo in TNF inhibitor–naive moderate-to-severe ulcerative colitis completed with po…
-
CLINICAL_TRIALS trial_result · 2021-04-05Clinical Trial Update: Safety and Efficacy of Etrasimod (APD334) in Patients With Ulcerative Colitis [Phase 2]
Phase 2 clinical trial assessing safety and efficacy of etrasimod (APD334) in patients with ulcerative colitis has completed with results po…
-
FDA approval · 2021-03-22FDA Approved: MESALAMINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Mesalamine from Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS trial_result · 2021-03-22Clinical Trial Update: Safety and Efficacy Study of PTG-100 in the Treatment of Moderate to Severe Ulcerative Colitis [Phase 2]
Phase 2 safety and efficacy study of PTG-100 for moderate to severe ulcerative colitis was terminated, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2021-03-15Clinical Trial Update: Mesalamine 4 g Sachet for the Induction of Remission in Active, Mild to Moderate Ulcerative Colitis (UC) [Phase 3]
Phase 3 trial update for mesalamine 4 g sachet used to induce remission in active, mild to moderate ulcerative colitis; study completed with…
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors [Phase 3]
Phase 3 trial assessing etrolizumab versus adalimumab and placebo in TNF-inhibitor-Naïve moderate-severe ulcerative colitis completed with p…
-
CLINICAL_TRIALS trial_result · 2021-03-04Clinical Trial Update: A Research Study to Bank Samples for Future Evaluation to Identify Biomarkers That Predispose Crohn's Disease and Ulcerative Colitis Patients to Develop Hepatosplenic T-Cell Lymphoma (HSTCL) [Phase 4]
A Phase 4 study sponsored by Janssen banked samples from Crohn's disease and ulcerative colitis patients to identify biomarkers that may pre…
-
CLINICAL_TRIALS trial_result · 2021-03-02Clinical Trial Update: Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease
Observational real-world study of Inflectra in inflammatory bowel disease completed with results posted.
-
FDA approval · 2021-02-24FDA Approved: ADALIMUMAB — Supplemental Application (Sandoz Inc)
FDA approval of a supplemental application for the adalimumab biosimilar ADALIMUMAB-ADAZ from Sandoz Inc.
-
CLINICAL_TRIALS trial_result · 2021-02-12Clinical Trial Update: Melatonin and Ulcerative Colitis: A Pilot Clinical Trial [Phase 2]
Phase 2 pilot trial investigating melatonin in ulcerative colitis; the study is terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-11Clinical Trial Update: Assessment of Metformin as Adjuvant Therapy in Patients With Ulcerative Colitis [Phase 2]
Phase 2 trial evaluating metformin as adjuvant therapy in patients with ulcerative colitis and inflammatory bowel diseases.
-
CLINICAL_TRIALS trial_result · 2021-02-10Clinical Trial Update: Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative Colitis [Phase 2]
Phase 2 trial evaluating antimicrobials versus placebo as an adjunct to fecal transplant therapy for ulcerative colitis has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-08Clinical Trial Update: Hyperbaric Oxygen Therapy for Ulcerative Colitis Flares [Phase 2]
Phase 2 trial evaluating hyperbaric oxygen therapy for flare-ups in ulcerative colitis has been completed.
-
CLINICAL_TRIALS trial_result · 2021-02-04Clinical Trial Update: Fecal Microbiota Transplantation in Pediatric Patients [Phase 1]
Phase 1 clinical trial evaluating fecal microbiota transplantation in pediatric patients with inflammatory bowel diseases, completed with re…
-
CLINICAL_TRIALS trial_result · 2021-02-01Clinical Trial Update: The Efficacy of Cobitolimod in Patients With Moderate to Severe Active Ulcerative Colitis [Phase 2]
Phase 2 trial update on cobitolimod for moderate to severe active ulcerative colitis showing completed results.